4//SEC Filing
Powala Christopher 4
Accession 0001209191-18-028859
CIK 0001557746other
Filed
May 8, 8:00 PM ET
Accepted
May 9, 4:19 PM ET
Size
10.1 KB
Accession
0001209191-18-028859
Insider Transaction Report
Form 4
Powala Christopher
Chief Operating Officer
Transactions
- Exercise/Conversion
Restricted Stock Units
2018-05-07−5,200→ 3,900 total→ Common Stock (5,200 underlying) - Exercise/Conversion
Common Stock
2018-05-07+5,200→ 138,801 total - Tax Payment
Common Stock
2018-05-07$18.10/sh−1,480$26,788→ 137,321 total
Holdings
- 130,434(indirect: By Trust)
Common Stock
Footnotes (4)
- [F1]Restricted stock units convert into common stock on a one-for-one basis.
- [F2]The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock units being reported in this Form 4.
- [F3]These shares are held by the Christopher V. Powala Aclaris Irrevocable Trust, for which Mr. Powala serves as trustee.
- [F4]On December 15, 2016, the reporting person was granted 10,400 restricted stock units. 50% of the shares underlying these restricted stock units vested on May 7, 2018 upon the achievement of a specified commercial milestone. The other 50% of the shares underlying the restricted stock units vest in four equal annual installments beginning on December 15, 2017, subject to the reporting person's continuous service with the issuer as of the applicable vesting date.
Documents
Issuer
Aclaris Therapeutics, Inc.
CIK 0001557746
Entity typeother
Related Parties
1- filerCIK 0001654301
Filing Metadata
- Form type
- 4
- Filed
- May 8, 8:00 PM ET
- Accepted
- May 9, 4:19 PM ET
- Size
- 10.1 KB